Getein Biotech Inc. (stock code: 603387), established in 2002, is a fully integrated in vitro diagnostic company that researches and develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits in point-of-care testing (POCT), clinical chemistry, chemiluminescent assays, hematology, coagulation, urinalysis and molecular diagnostics. The company sits on a 10.5 square kilometers science park and is equipped with state-of-the-art R&D and production facilities. We also manufacture analytic medical devices and a variety of biological and non-biological raw materials for applications in diagnostics.
Getein One Step Test for SARS-CoV-2 Total Antibody/ Neutralizing Antibody (Colloidal Gold) is used to monitor the presence of neutralizing antibodies in subjects vaccinated with the novel coronavirus vaccine or in people infected with the novel coronavirus.
Getein Novel Coronavirus (2019-nCoV) Real-time RT-PCR Kit is used for the qualitative detection of nucleic acid from the 2019-nCoV in oropharyngeal swabs and bronchoalveolar lavage fluid collected form individuals suspected of COVID-19 by their healthcare provider.
Getein FluA/ FluB/ SARS-CoV-2 Real-time RT-PCR Kit is used to quickly identify whether a patient is infected with influenza A, influenza B or SARS-CoV-2, thereby effectively controlling viral infection.
Getein PCT Fast Test Kit is used as an aid in the assessment and evaluation of patients suspected of bacterial infection, trauma or shock.
Getein Cardiac Troponin I Fast Test Kit is used as an aid in the diagnosis of myocardial injury such as Acute Myocardial Infarction (AMI), Unstable Angina, Acute Myocarditis and Acute Coronary Syndrome (ACS).
Getein hs-cTnI Fast Test Kit can be used as an aid in the diagnosis of myocardial infarction (MI).
Getein CK-MB Fast Test Kit is used as an aid in the clinical diagnosis, prognosis and evaluation of myocardial injury such as Acute Myocardial Infarction (AMI), Unstable Angina, Acute Myocarditis and Acute Coronary Syndrome (ACS).
Getein PCT/CRP Fast Test Kit is used to identify systemic or local infection, bacterial infection or virus infection, determine the severity of infection and instruct clinical use of antibiotics.
Getein hs-CRP+CRP Fast Test Kit is useful for the detection and evaluation of infection, tissue injury and inflammatory disorders.
Getein Cardiac Troponin l Fast Test Kit (Colloidal Gold) is intended for in vitro qualitative and semi-quantitative determination of cardiac Troponin l (cTnl) in serum, plasma or whole blood.
Getein TnT Fast Test Kit is used as an aid for the early screening of acute myocardial infarction (AMI), heart failure, unstable angina pectoris, myocarditis and other myocardial injuries, it can also be used for the assessment of prognosis and risk stratification of acute pulmonary embolism and the monitoring of myocardial injury in thoracic surgery.
Getein ST2 Fast Test Kit is used in conjunction with clinical evaluation as an aid in assessing the prognosis of patients diagnosed with chronic heart failure.
Getein NT-proBNP Fast Test Kit is used as an aid in the clinical diagnosis, prognosis and evaluation of Heart Failure (HF).
Getein H-FABP Fast Test Kit is used in the early diagnosis of AMI and pulmonary embolism, and monitoring of chronic heart failure.
Getein CK-MB/cTnI/Myo Fast Test Kit is used as an aid in the clinical diagnosis, prognosis and evaluation of myocardial injury such as Acute Myocardial Infarction (AMI), Unstable Angina, Acute Myocarditis and Acute Coronary Syndrome (ACS).
Getein CK-MB/cTnI/H-FABP Fast Test Kit is used as an aid in the clinical diagnosis, prognosis and evaluation of myocardial injury such as Acute Myocardial Infarction (AMI), Unstable Angina, Acute Myocarditis and Acute Coronary Syndrome (ACS).
Getein CK-MB/cTnI Fast Test Kit is used as an aid in the clinical diagnosis, prognosis and evaluation of myocardial injury such as Acute Myocardial Infarction (AMI), Unstable Angina, Acute Myocarditis and Acute Coronary Syndrome (ACS).
Getein BNP Fast Test Kit is used as an aid in the diagnosis of congestive heart failure and for the risk stratification of patients with acute coronary syndromes (ACS).
Subscribe to our weekly newsletter and receive exclusive offers on products you love!
X
